Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks finish mixed as US GDP growth slows

Thu, 25th Apr 2024 15:14

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

The FTSE 100 finished up 0.48%, closing at 8,078.86 points, while the FTSE 250 slipped 0.6% to 19,601.98 points.

In currency markets, sterling was last up 0.22% on the dollar to trade at $1.2492, while it managed gains of 0.04% against the euro, changing hands at €1.1654.

"The FTSE 100 reached a new all-time high on Thursday, driven by a surge in miner Anglo American's stock following a buyout offer from BHP Group," said TickMill market analyst Patrick Munnelly.

"Additionally, investors were pleased with the strong financial results from several leading companies such as Unilever, AstraZeneca, and Barclays."

Munnelly noted that after BHP's announcement of a buyout offer for Anglo American, the London-listed miner's shares soared to their highest level in nine months.

"If successful, this deal would establish the world's largest copper miner, accounting for approximately 10% of global output.

"However, BHP's stock on the UK market experienced a decline in response to the news."

US GDP growth comes in slower than expected, UK retail sales decline

In economic news, activity in the United States faced a larger slowdown than expected at the start of the year, according to fresh data from the Department of Commerce.

Gross domestic product (GDP) grew at a quarterly annualised pace of 1.6%, down from the prior quarter's 3.4% rate and below the consensus forecast of 2.5%.

At the same time, the core price deflator for personal consumption expenditures increased to 3.7% from 2.0% in the prior quarter, indicating rising price pressures.

Factors contributing to the GDP slowdown included reduced consumption, increased imports, decreased inventory building, and a slowdown in public sector spending.

However, private domestic investment expanded 3.2%, a notable improvement from the previous quarter.

"As for the growth outlook, we expect to see more subdued activity in upcoming quarters," said James Knightley, chief international economist at ING.

"The divergence between business surveys and official data is very wide.

"We strongly suspect that business caution will translate into weaker hiring and wage growth and subdued business capex, and that will eventually show up in the official GDP data."

On home shores, the UK retail sector encountered an unexpected decline in sales in April, according to the Confederation of British Industry's (CBI) distributive trades survey.

The retail sales volumes gauge plummeted to -44 from 2 in March, accompanied by a decline in orders placed with suppliers to -49 from -22.

Retailers expressed pessimism regarding future sales and orders, with expectations of further declines in May, albeit at a slower pace.

The CBI attributed the surprise slump partly to the timing of Easter this year.

"April's sharp fall was likely related to the earlier timing of Easter this year, so we should take it with a pinch of salt," said Alpesh Paleja, CBI lead economist.

"Indeed, the sector is likely to benefit from some favourable tailwinds this year, as falling inflation continues to drive growth in households' real earnings

"That being said, conditions do remain challenging on the ground; April's fall in sales was faster than expected and retailers aren't overly hopeful about the month ahead.

On the continent, German consumer sentiment continued to strengthen, as indicated by the latest GfK consumer climate indicator.

Heading into May, the indicator rose to -24.2, the highest level in two years and surpassing forecasts for -25.9.

The improvement marked the third consecutive monthly rise.

Anglo American surges on BHP offer, ex-divs drag on the downside

On London's equity markets, Anglo American soared 16.1% following confirmation of an unsolicited takeover proposal from Australia's BHP Group.

The offer, worth £31.1bn, offered shareholders of the London-listed miner 0.7097 BHP shares for each Anglo share.

Elsewhere, AstraZeneca saw a notable uptick of 5.65% after reporting an 18% increase in first-quarter revenues, driven by robust sales of its cancer drugs, surpassing market expectations.

Barclays edged up 2.52%, despite a 12% decline in first-quarter profit, buoyed by slightly better-than-expected results.

Hikma Pharmaceuticals also made gains of 2.26%, driven by a strong performance across all business segments in 2024.

On the downside, J Sainsbury fell 4.25% despite the grocer surpassing earnings expectations for the year.

Trainline plummeted by 11.95%, coinciding with the Labour Party's pledge to renationalise Britain's railways if elected.

Online greeting cards and gift retailer Moonpig slid by 12.73% after a discounted share placement by certain shareholders.

WH Smith also experienced a sharp decline of 6.04%, despite expressing confidence in meeting full-year expectations, as its first-half results underwhelmed.

Legal & General Group, Greggs, Bakkavor Group, St James's Place, and Morgan Sindall Group all traded lower after going ex-dividend, affecting shareholder payouts.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 8,078.86 0.48%

FTSE 250 (MCX) 19,601.98 -0.60%

techMARK (TASX) 4,515.55 0.36%

FTSE 100 - Risers

Anglo American (AAL) 2,560.00p 16.10%

Barclays (BARC) 204.00p 6.73%

AstraZeneca (AZN) 12,026.00p 5.94%

Unilever (ULVR) 4,082.00p 5.67%

Antofagasta (ANTO) 2,227.00p 2.82%

Hikma Pharmaceuticals (HIK) 1,854.00p 2.26%

NATWEST GROUP (NWG) 289.80p 1.36%

Imperial Brands (IMB) 1,827.50p 1.27%

Marks & Spencer Group (MKS) 260.70p 1.12%

London Stock Exchange Group (LSEG) 8,890.00p 0.93%

FTSE 100 - Fallers

Legal & General Group (LGEN) 232.80p -6.36%

Schroders (SDR) 347.20p -5.45%

St James's Place (STJ) 421.00p -5.18%

Sainsbury (J) (SBRY) 256.60p -4.25%

Pershing Square Holdings Ltd NPV (PSH) 3,838.00p -3.91%

Convatec Group (CTEC) 275.60p -3.30%

Spirax-Sarco Engineering (SPX) 8,850.00p -3.28%

BAE Systems (BA.) 1,320.00p -3.19%

Prudential (PRU) 714.00p -2.88%

Rolls-Royce Holdings (RR.) 405.70p -2.71%

FTSE 250 - Risers

Inchcape (INCH) 786.50p 9.32%

Senior (SNR) 163.80p 2.37%

Drax Group (DRX) 524.00p 2.24%

Tritax Eurobox (GBP) (EBOX) 51.00p 2.19%

Hipgnosis Songs Fund Limited NPV (SONG) 103.60p 2.17%

Oxford Instruments (OXIG) 2,225.00p 2.06%

W.A.G Payment Solutions (WPS) 66.20p 1.85%

Hochschild Mining (HOC) 159.60p 1.79%

Ferrexpo (FXPO) 51.90p 1.76%

Bank of Georgia Group (BGEO) 5,290.00p 1.73%

FTSE 250 - Fallers

Moonpig Group (MOON) 155.00p -12.73%

Trainline (TRN) 302.00p -11.95%

Indivior (INDV) 1,400.00p -7.53%

Auction Technology Group (ATG) 493.00p -6.98%

Watches of Switzerland Group (WOSG) 334.20p -6.07%

WH Smith (SMWH) 1,182.00p -6.04%

Mobico Group (MCG) 52.85p -5.63%

Tyman (TYMN) 374.00p -4.83%

Bakkavor Group (BAKK) 117.50p -4.47%

FirstGroup (FGP) 163.70p -4.10%

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.